Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.
OBJECTIVE
The present investigation is to study the influence of metronidazole and tinidazole on the usefulness of guar gum, a colon-specific drug carrier based on the metabolic activity of colonic bacteria, using matrix tablets of albendazole (containing 20% of guar gum) as a model formulation.


METHODS
The matrix tablets of albendazole were subjected to in vitro drug release studies in simulated colonic fluids (4%w/v of rat caecal contents) obtained after oral treatment of rats for 7 days either with varying doses of metronidazole/ tinidazole and 1 mL of 2%w/v of guar gum or with 1 mL of 2%w/v of guar gum alone (control study) after completing the dissolution study in 0.1 M HCl (2 h) and pH 7.4 Sorensen's phosphate buffer (3 h).


RESULTS
The guar gum matrix tablets of albendazole were found degraded by colonic bacteria of rat caecal contents and released about 44% of albendazole in simulated colonic fluids (control study) at the end of 24 h indicating the susceptibility of the guar gum formulations to the rat caecal contents. However, the release of albendazole decreased when the drug release studies were carried out in caecal contents of rats treated for 7 days with either metronidazole (10-50 mg/ kg once daily) or tinidazole (10-30 mg/ kg once daily), and the release of albendazole from the matrix tablets was found to be dose dependent. The release of the drug from guar gum formulations was found to increase with a decrease in the dose of metronidazole/tinidazole administered. The antimicrobial activity of metronidazole/ tinidazole against the anaerobic bacteria of the rat"s GI flora might have been inhibited to a varying degree depending on the dose of metronidazole/tinidazole administered.


CONCLUSIONS
The results of the study showed that concomitant administration of either metronidazole or tinidazole with guar gum based colon-specific drug delivery systems may interfere with the targeting of drugs to colon.
Krishnaiah
Y S
YS
Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, India. krishnaysr112@rediffmail.com
Seetha Devi
A
A
Nageswara Rao
L
L
Bhaskar Reddy
P R
PR
Karthikeyan
R S
RS
Satyanarayana
V
V
D000284:Administration, Oral; D015766:Albendazole / Q000008:administration & dosage* / Q000378:metabolism*; D000818:Animals; D003106:Colon / Q000378:metabolism*; D004043:Dietary Fiber / Q000378:metabolism; D016503:Drug Delivery Systems; D005243:Feces / Q000737:chemistry; D005685:Galactans / Q000378:metabolism*; D008297:Male; D008351:Mannans / Q000378:metabolism*; D008795:Metronidazole / Q000494:pharmacology*; D009928:Organ Specificity / Q000187:drug effects / Q000502:physiology; D010936:Plant Extracts / Q000378:metabolism; D053149:Plant Gums; D051381:Rats; D013607:Tablets; D014011:Tinidazole / Q000494:pharmacology*
D004043:Dietary Fiber; D005685:Galactans; D008351:Mannans; D010936:Plant Extracts; D053149:Plant Gums; D013607:Tablets; D014011:Tinidazole; D008795:Metronidazole; C007894:guar gum; D015766:Albendazole